ArticleInvestigational new drugs2019

Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model.

Weijing Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.